• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, Aug. 26

Aurobindo Pharma Ltd has announced that its wholly-owned subsidiary in South Africa has received the approval for four of its anti-retrovirals (ARVs) from the Medicines Control Council of South Africa. In a press release here on Saturday, the company said the four products meant for the treatment of HIV infection include lamivudine tablets 150 mg, zidovudine tablets 300 mg, nevirapine tablets 200 mg and combo drug of lamivudine 150 mg and zidovudine 300 mg.

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Dunlop's Ambattur unit to restart production

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line